OvaScience to Present at Upcoming Investor Conferences in March
OvaScience? (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Christophe Couturier, Chief Financial Officer of OvaScience, will present a corporate overview at two upcoming conferences:
Cowen and Company 37th Annual Health Care ConferenceDate: Monday, March 6, 2017Time: 2:00 p.m. ETLocation: Boston, MA
Oppenheimer 27th Annual Healthcare ConferenceDate: Tuesday, March 21, 2017Time: 3:55...